Abstract
Purpose: The expression of an array of signaling molecules, along with the assessment of real-time cell proliferation, has been performed in U87 glioma cell line and in patients' glioblastoma established cell cultures in order to provide a better understanding of cellular and molecular events involved in glioblastoma pathogenesis. Experimental therapy was performed using a phosphatydylinositol-3′-kinase (PI3K) inhibitor. Patients and methods: xMAP technology was employed to assess expression levels of several signal transduction molecules and real-time xCELLigence platform for cell behavior. Results: PI3K inhibition induced the most significant effects on global signaling pathways in patient-derived cell cultures, especially on members of the mitogen-activated protein-kinase family, P70S6 serine-threonine kinase, and cAMP response element-binding protein expression and further prevented tumor cell proliferation. Conclusion: The PI3K pathway might be a prime target for glioblastoma treatment. © 2013 Cruceru et al.
Author supplied keywords
Cite
CITATION STYLE
Cruceru, M. L., Enciu, A. M., Popa, A. C., Albulescu, R., Neagu, M., Tanase, C. P., & Constantinescu, S. N. (2013). Signal transduction molecule patterns indicating potential glioblastoma therapy approaches. OncoTargets and Therapy, 6, 1737–1749. https://doi.org/10.2147/OTT.S52365
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.